GlassScriptPhysician profile
Justin Kearse
NPI 1548321599
$1,527.71
in general payments reported to CMS, 2019-2025
11 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.45 · 2020: $247 · 2021: $469 · 2022: $313 · 2023: $227 · 2024: $116 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $876.79 | 2019-2024 | Variax |
| Endo Pharmaceuticals INC. | $245.04 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $87.20 | 2024-2025 | Xiaflex |
| Electronic Waveform Lab, INC. | $70.31 | 2021 | |
| Orthofix Medical, INC. | $65.33 | 2024-2025 | Spinal-Stim, Physio-Stim |
| Horizon Therapeutics Plc | $52.98 | 2021-2022 | |
| Encore Medical, LP | $47.75 | 2023 | Djo Surgical |
| Djo, LLC | $40.31 | 2020-2023 | Cmf |
| Avanos Medical | $17.93 | 2024 | Trivisc Sodium Hyaluronate |
| Dynasplint Systems INC. | $12.87 | 2023 | Dynasplint |
| Sonex Health, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Kearse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.